Following recent weakness, should you buy the dip on CSL Ltd (ASX: CSL) shares today amid the company's push for long-term ...
Stockhead on MSN
Health Check: Less pain at Mayne after knock-out court win
The NSW Supreme Court has ruled in favour of Mayne Pharma, in a stoush over suitor Cosette's now-reluctant $670 million takeover offer.
The US president’s erratic approach to pharmaceutical pricing won’t do much to help Americans. But what about Australians?
Google LLC’s DeepMind research unit is partnering with the nuclear fusion startup Commonwealth Fusion Systems LLC to see if ...
Due largely to CSL, Merck and Novo Nordisk’s reorganizations that could total about 19,350 people, Q3 cuts rose significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback